ABCA1 |
ATP-binding cassette: sub-family A, member 1 |
ACS |
acute coronary syndrome |
ADAM10 |
a disintegrin and metalloproteinase domain-containing protein 10 |
AGEs |
advanced-glycation end-products |
AGO |
Argonaute |
Agr-1 |
argininase-1 |
AMPK |
adenosine monophosphate-activated protein kinase |
ApoA-1 |
apolipoprotein A-1 |
AUC |
area under the curve |
BMI |
body mass index |
CAC |
coronary artery calcification |
CAD |
coronary artery disease |
CAV-1 |
caveolin 1 |
CCL-2 |
chemokine CC-motif ligand 2 |
CCS |
chronic coronary syndrome |
CI |
confidence interval |
circRNA |
circular RNA |
COX |
cyclooxygenase |
DAXX |
death-domain associated protein |
DGCR8 |
DiGeorge syndrome Critical Region 8 |
EC |
endothelial cell |
ECM |
extracellular matrix |
EDCF |
endothelium-derived cyclooxygenase-dependent contracting factor |
EMP2 |
epithelial membrane protein 2 |
EndMT |
endothelial-to-mesenchymal transition |
eNOS |
endothelial nitric oxide synthase |
EPC |
endothelial progenitor cell |
ERK |
extracellular signal-regulated kinase |
ET-1 |
endothelin-1 |
EVs |
extracellular vesicles |
EXP5 |
Exportin-5 |
FSP-1 |
fibroblast specific protein-1 |
GLUT-4 |
glucose transporter-4 |
GS |
Gensini score |
HbA1c |
glycated hemoglobin A1c |
HDL-C |
high-density lipoprotein cholesterol |
HMGB1 |
high mobility group box-1 |
HSC70 |
heat shock cognate 70 |
HSP90 |
heat shock protein 90 |
ICAM-1 |
intercellular adhesion molecule-1 |
IGF-1R |
insulin-like growth factor-1 receptor |
IFN-γ |
interferon-γ |
IL |
interleukin |
IRAK1 |
interleukin 1 receptor associated kinase 1 |
IRS-1 |
insulin receptor substrate 1 |
JNK |
c-Jun N-terminal kinase |
KLF |
Krüppel-like factor |
KRAS |
Kirsten Rat Sarcoma Viral Oncogene Homolog |
LDL-C |
low-density lipoprotein cholesterol |
LNA |
locked nucleic acid |
lncRNA |
long non-coding RNA |
α-SMA |
alpha smooth muscle actin |
MAPK |
mitogen-activated protein kinase |
MCP-1 |
monocyte chemoattractant protein-1 |
MEK |
mitogen-activated protein kinase |
MGO |
methylglyoxal |
MPO |
myeloperoxidase |
mRNA |
messenger RNA |
miRNA, miR |
microRNA |
mTOR |
mammalian target of rapamycin |
NADPH |
nicotinamide adenine dinucleotide phosphate |
ncRNA |
non-coding RNA |
NF-κB |
nuclear factor-kappa B |
NGS |
next-generation sequencing |
NO |
nitric oxide |
NPM1 |
nucleophosmin 1 |
OR |
odds ratio |
ox-LDL |
oxidized low-density lipoprotein |
PAI-1 |
plasminogen activator inhibitor-1 |
PBMC |
peripheral blood mononuclear cell |
PDGF |
platelet-derived growth factor |
PDGFRβ |
platelet-derived growth factor receptor beta |
PECAM-1 |
platelet endothelial cell adhesion molecule-1 |
PHLPP2 |
PH domain leucine-rich repeat protein phosphatase 2 |
PI3K |
phosphatidylinositol 3-kinase |
piRNA |
PIWI-interacting RNA |
PKC |
protein kinase C |
pre-miRNA |
precursor miRNA |
pri-miRNA |
primary miRNA |
RAGE |
receptor for advanced glycation end-products |
RISC |
RNA-induced silencing complex |
RNA pol II |
RNA polymerase II |
ROC |
receiver operating characteristic |
ROCK1 |
Rho-associated coiled-coil forming protein kinase 1 |
ROS |
reactive oxygen species |
RT-qPCR |
real-time polymerase chain reaction |
siRNA |
small interfering RNA |
SM22α |
smooth muscle protein 22 alpha |
sncRNA |
small non-coding RNA |
Spred-1 |
sprouty-related, EVH1 domain-containing protein 1 |
sRAGE |
soluble receptor for advanced glycation end-products |
SREBP |
sterol regulatory element-binding protein |
SRF |
serum-response factor |
SYNTAX |
Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery |
T2DM |
type 2 diabetes mellitus |
TC |
total cholesterol |
TG |
triglycerides |
TGF-β |
transforming growth factor-β |
TNF-α |
tumor necrosis factor α |
TPM1 |
tropomyosin 1 |
TRAF6 |
tumor necrosis factor receptor associated factor 6 |
TRBP |
trans-activation response RNA binding protein |
3′ UTR |
3′ untranslated region |
WHR |
waist-to-hip ratio |
VCAM-1 |
vascular cell adhesion molecule-1 |
VE-cadherin |
vascular endothelial cadherin |
VEGF |
vascular endothelial growth factor |
VSMC |
vascular smooth muscle cell |
vWF |
von Willebrand Factor |